gliclazide has been researched along with Pneumonia in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The onset of his hypoglycemia occurred within days after starting voriconazole and subsequently fluconazole for a fungal pneumonia." | 3.88 | Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. ( Austin, E; Gunaratne, K; Wu, PE, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunaratne, K | 1 |
| Austin, E | 1 |
| Wu, PE | 1 |
1 other study available for gliclazide and Pneumonia
| Article | Year |
|---|---|
Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Drug Interactions; Fluconazole; Gliclazide; Humans; Hy | 2018 |